Wellness and the Role of Comorbidities in Multiple Sclerosis.
Study Goal
The researchers aimed to evaluate the potential role of tobacco smoking cessation as an adjunct therapy to disease-modifying therapies (DMTs) in managing multiple sclerosis (MS).
Results Summary
The study suggests that tobacco smoking cessation may help mitigate disease-related complications in MS, alongside other lifestyle strategies, though the evidence is not conclusive.
Population
Individuals with multiple sclerosis (MS).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
disease modifying therapies (DMTs) | decrease | inflammatory disease activity | patients with multiple sclerosis | - | reduce | #1 |
disease modifying therapies (DMTs) | decrease | worsening disability | patients with multiple sclerosis | - | slow | #2 |
lifestyle strategies | increase | wellness | patients with multiple sclerosis | - | support | #3 |
lifestyle strategies | decrease | disease-related complications | patients with multiple sclerosis | - | mitigate | #4 |
vitamin D supplementation | decrease | disease activity | patients with multiple sclerosis | - | potential role | #5 |
tobacco smoking cessation | decrease | disease activity | patients with multiple sclerosis | - | potential role | #6 |
routine exercise | decrease | disease activity | patients with multiple sclerosis | - | potential role | #7 |
plant-based, anti-inflammatory diet | decrease | disease activity | patients with multiple sclerosis | - | potential role | #8 |
maintenance of emotional well-being | decrease | disease activity | patients with multiple sclerosis | - | potential role | #9 |
lifestyle strategies | increase | overall health and well-being | patients with multiple sclerosis | - | should be emphasized | #10 |
Multiple sclerosis (MS) is a demyelinating and neurodegenerative disorder of the central nervous system, for which disease modifying therapies (DMTs) are the mainstay treatment approach to reduce inflammatory disease activity and slow worsening disability. In addition to conventional pharmacologic therapy, there is growing interest in the use of lifestyle strategies to support wellness and mitigate disease-related complications in MS. This interest stems from a growing appreciation of the role of certain comorbidities and lifestyle factors on disease activity, disability, mortality, and overall quality of life. While the current literature is not conclusive, there is evidence to suggest a potential role for vitamin D supplementation, tobacco smoking cessation, routine exercise, a plant-based, anti-inflammatory diet, and maintenance of emotional well-being as adjunct therapies to DMTs. In addition to DMTs, lifestyle strategies should be emphasized as part of a management plan focused on overall health and well-being.